<DOC>
	<DOCNO>NCT00362596</DOCNO>
	<brief_summary>Herpes infection important co-factor HIV transmission . A recent meta-analysis demonstrate HSV infection contribute 2-fold increased risk HIV transmission . Suppressive therapy acyclovir method propose reduce HIV transmission . We conduct randomize control cross-over trial evaluate effect acyclovir suppressive therapy HIV genital shed woman co-infected HIV-1 Herpes Simplex Virus Type-2 ( HSV-2 ) Thailand .</brief_summary>
	<brief_title>A Randomized Controlled Trial Acyclovir Among HIV HSV-2 Co-Infected Women , Chiang Rai , Thailand</brief_title>
	<detailed_description>65 woman age 18-49 year old HIV-1 HSV-2 co-infection recruit general medicine clinic , family planning clinic , postnatal clinic , community base organization community outreach Chiang Rai , Thailand . Our study objective : - To evaluate effect acyclovir suppressive therapy HIV genital shed . - To determine association HIV HSV genital shedding , effect acyclovir suppressive therapy association . - To determine acceptability acyclovir suppressive therapy woman HIV infection . - To evaluate association genital symptom HIV HSV genital shedding . - To evaluate association cervicovaginal ( CVL ) specimens self-collected genital swab detection HIV HSV-2 .</detailed_description>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>participant HIV HSV2 seropositive pregnancy , CD4 count &lt; 200 , ART</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Acyclovir</keyword>
	<keyword>HIV</keyword>
	<keyword>HSV</keyword>
</DOC>